Truth Seeker @JacksRule
02 December, 11:36
Pfizer is facing scrutiny after the drugmaker last week published Phase 3 clinical trial results for its mRNA flu vaccine in the New England Journal of Medicine (NEJM) — but excluded the trial’s data for adults 65 and older.

The data on ClinicalTrials.gov, showed elderly participants who received the mRNA flu shot faced a greater risk of serious adverse events, including kidney failure & acute respiratory failure.

Daniel O’Connor, founder of TrialSite News, said the NEJM’s exclusion of “a full high-risk cohort is extremely unusual and suggests a strategic de-emphasis of negative findings.”

“When a top-tier journal quietly omits an entire high-risk population — and that population shows no benefit and higher harm — you’re not looking at science. You’re looking at a profound breach of trust with reckless disregard,” O’Connor said.

READ MORE:
https://childrenshealthdef...

Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Myra Raney @myralynnr
I begged my mother not to take her last flu shot, but she got it anyway. Within a week her lungs were very congested and she was very sick. Then the UTI's started. She would just get over one round of antibiotics, and another UTI would happen. Her last hospitalization was for IV antibiotics and then I got the call from her Dr. He said she no longer was responding to the antibiotics, told me to call Hospice, there was nothing more they could do. I will always believe that flu shot led to my mom's demise.
04:28 AM - Dec 03, 2025
In response Truth Seeker to his Publication
Only people mentioned by myralynnr in this post can reply

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from Myra Raney, click on at the bottom under it